Nyxoah’s Genio® Secures Prix Galien UK 2026 Award for Best Medical Technology

Nyxoah’s implantable device Genio® has been honored with the Prix Galien UK 2026 award. The accolade recognizes the product as the best medical technology of the year. Genio® is designed to treat patients with obstructive sleep apnea. The award highlights the device’s innovative approach and clinical impact. Nyxoah’s CEO praised the achievement as validation of their research efforts. The recognition may enhance the company’s visibility among healthcare investors. Industry analysts anticipate broader adoption of the technology following the win. Future studies will assess the long‑term outcomes of patients using Genio®.